We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$6.49B
AUM Growth
-$91.2M
Cap. Flow
-$150M
Cap. Flow %
-2.31%
Top 10 Hldgs %
18.45%
Holding
1,603
New
478
Increased
239
Reduced
260
Closed
489

Sector Composition

Rank Sector Weight
1 Communication Services 3.18%
2 Healthcare 3.02%
3 Financials 2.03%
4 Technology 1.9%
5 Consumer Discretionary 0.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCUS icon
726
CALL
Arcus Biosciences
RCUS
$3.48B
$751K 0.01%
+49,300
New +$796K
PLAY icon
727
Dave & Buster's
PLAY
$400M
$748K 0.01%
18,800
+900
+5% +$46.7K
KRNT icon
728
PUT
Kornit Digital
KRNT
$724M
$732K 0.01%
+50,000
New +$771K
GTHX
729
PUT
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$731K 0.01%
320,800
+141,400
+79% +$540K
OKLO
730
Oklo
OKLO
$7.18B
$728K 0.01%
+85,971
New +$967K
DLO icon
731
CALL
dLocal
DLO
$4.48B
$728K 0.01%
+90,000
New +$1.06M
OGN icon
732
Organon & Co
OGN
$3.56B
$725K 0.01%
35,000
-67,300
-66% -$1.34M
IMVT icon
733
Immunovant
IMVT
$7.97B
$724K 0.01%
27,436
-86,041
-76% -$2.45M
ALKS icon
734
CALL
Alkermes
ALKS
$8.48B
$723K 0.01%
30,000
-8,500
-22% -$208K
ALKS icon
735
PUT
Alkermes
ALKS
$8.48B
$723K 0.01%
30,000
ELAN icon
736
Elanco Animal Health
ELAN
$12.8B
$722K 0.01%
50,000
-169,054
-77% -$2.7M
ANVS icon
737
PUT
Annovis Bio
ANVS
$74.4M
$720K 0.01%
125,000
-31,500
-20% -$255K
GAP
738
CALL
The Gap Inc
GAP
$7.25B
$717K 0.01%
+30,000
New +$698K
PAYO icon
739
Payoneer
PAYO
$2.41B
$707K 0.01%
127,600
-201,751
-61% -$1.09M
APEI icon
740
CALL
American Public Education
APEI
$921M
$703K 0.01%
+40,000
New +$628K
SEE
741
DELISTED
Sealed Air
SEE
$703K 0.01%
20,200
+10,800
+115% +$385K
HLF icon
742
PUT
Herbalife
HLF
$1.31B
$701K 0.01%
67,500
NXE icon
743
CALL
NexGen Energy
NXE
$6.3B
$698K 0.01%
+100,000
New +$766K
DNLI icon
744
CALL
Denali Therapeutics
DNLI
$3.68B
$697K 0.01%
+30,000
New +$576K
DNLI icon
745
PUT
Denali Therapeutics
DNLI
$3.68B
$697K 0.01%
+30,000
New +$576K
KOS icon
746
CALL
Kosmos Energy
KOS
$1.54B
$693K 0.01%
125,000
TEVA icon
747
Teva Pharmaceuticals
TEVA
$39.6B
$692K 0.01%
+42,600
New +$656K
ARQT icon
748
CALL
Arcutis Biotherapeutics
ARQT
$3.29B
$691K 0.01%
+74,300
New +$672K
HBI
749
DELISTED
Hanesbrands
HBI
$690K 0.01%
140,000
+3,980
+3% +$19.5K
FTI icon
750
TechnipFMC
FTI
$27.2B
$671K 0.01%
25,647
+2,289
+10% +$59K

Similar funds

Caption Management's Q2 2024 Portfolio in Review

As of Q2 2024, Caption Management held 1,603 positions worth $6.49B, down 1.4% from $6.59B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management's Q2 2024 filing shows 478 new, 239 increased, 260 reduced and 489 closed positions. Its largest new stake was Alphabet (Google) Class C: 233,700 shares worth $42.9M. The largest sale was Meta Platforms (Facebook), an estimated $25.5M.

By sector, the portfolio is most concentrated in Communication Services at 3.2% of assets, up from 2.6% a quarter earlier, followed by Healthcare and Financials.

  • Caption Management's largest Q2 2024 buy was Alphabet (Google) Class C: 233,700 shares worth $42.9M.
  • Caption Management added most to First Solar in Q2 2024, an estimated $18.5M increase.
  • Caption Management's biggest Q2 2024 reduction was Intra-Cellular Therapies Inc., cutting an estimated $18.5M.
  • Caption Management fully exited Meta Platforms (Facebook) in Q2 2024, selling an estimated $25.5M.
  • Caption Management's ten largest holdings make up 18% of its $6.49B portfolio in Q2 2024.
  • Caption Management opened 478 new positions and closed 489 in Q2 2024.
  • Caption Management's portfolio value fell 1.4% quarter-over-quarter to $6.49B.

Based on Caption Management's 13F filing for Q2 2024, filed 14 Aug 2024.